Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ReVision Optics

ReVision Optics
1996 FOUNDED
OOB STATUS
51-60 EMPLOYEES
Out of Business LATEST DEAL TYPE
Description

Developer of optical technology intended to help in the treatment of presbyopia. The company's technology is used to do a patented refractive surgery to improve near vision that has been lost by the eye's natural aging process, enabling physicians to treat their patients in an enhanced way and give them better eye sight.

Formerly Known As
IntraLens Vision, Anamed
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Surgical Devices
Other Healthcare Technology Systems
Primary Office
  • 25651 Atlantic Ocean Drive
  • Suite A1
  • Lake Forest, CA 92630
  • United States

+1 (949) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ReVision Optics’s full profile, request a free trial.

ReVision Optics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Out of Business 30-Jan-2018 00000 Completed Out of Business
9. Later Stage VC (Series F) 10-Nov-2016 0000 00000 00000 Completed Generating Revenue
8. Debt - General 18-Aug-2016 0000 00000 Completed Generating Revenue
7. Later Stage VC (Series E) 29-Jul-2013 000.00 00000 00000 Completed Generating Revenue
6. Later Stage VC (Series E) 16-Apr-2013 0000 000.00 00000 Completed Generating Revenue
5. Later Stage VC (Series E) 25-May-2010 0000 000.00 000.00 Completed Generating Revenue
4. Later Stage VC (Series D) 14-May-2007 0000 000.00 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 19-Oct-2005 0000 000.00 000.00 Completed Generating Revenue
2. Later Stage VC (Series B) 25-Sep-2003 $2.77M $5.19M 000.00 Completed Generating Revenue
1. Later Stage VC 25-Sep-2003 $2.42M $2.42M Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

ReVision Optics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series F 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series E 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.00
Series D 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series C 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series B 247,326 $0.000100 8% $11.22 $11.22 1x $11.22 0.29%
Series A 269,500 $0.000100 8% $9.09 $9.09 1x $9.09 0.31%
To view this company’s complete Cap Table, request access »

ReVision Optics Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000000 Formerly VC-backed Waltham, MA 000 00000 00000000 00000
To view this company’s complete list of competitors, request access »

ReVision Optics Executive Team (11)

Name Title Board
Seat
Contact
Info
Louis Bunn Chief Financial Officer
Michael Crompton Vice President, Regulatory Affairs & Quality Assurance and Chief Compliance Officer
Luis Vargas MD Vice President of Medical Affairs and Medical Director
Sarah Cannon Director of Global Marketing
Lynne Archer Vice President of Clinical Affairs

3 Former Executives

You’re viewing 5 of 11 executives. Get the full list »

ReVision Optics Board Members (15)

Name Representing Role Since Contact
Info
Frank Fischer Self Board Member 000 0000
Inna Eitan ReVision Optics Board Member 000 0000
Jay Holmes Self Board Member 000 0000
Randy Alexander Self Chairman 000 0000
Stephen Slade MD Self Board Member 000 0000

10 Former Board Members

You’re viewing 5 of 15 board members. Get the full list »